Amgen (AMGN) Announces Servier Exercises Option to Commercialize Omecamtiv Mecarbil in Europe
Tweet Send to a Friend
Amgen (NASDAQ: AMGN) and Servier today announced an advancement in their cardiovascular collaboration, with Servier's decision to exercise its option ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE